BWM
GSK icon

Baystate Wealth Management’s GSK GSK Stock Holding History

Baystate Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40
Closed -$2K – 908
2022
Q2 		$2K Buy
+40
New +$2.21K ﹤0.01% 756
2017
Q4 		– Sell
-107
Closed -$5K – 676
2017
Q3 		$5K Sell
107
-4,309
-98% -$219K ﹤0.01% 407
2017
Q2 		$233K Buy
4,416
+60
+1% +$3.2K 0.04% 70
2017
Q1 		$228K Sell
4,356
-49
-1% -$2.49K 0.04% 71
2016
Q4 		$215K Sell
4,405
-6
-0.1% -$296 0.04% 58
2016
Q3 		$238K Buy
4,411
+1
+0% +$55 0.05% 47
2016
Q2 		$239K Buy
+4,410
New +$232K 0.05% 49
2013
Q3 		– Sell
-156
Closed -$10K – 99
2013
Q2 		$10K Buy
+156
New +$9.9K ﹤0.01% 186

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Baystate Wealth Management's GSK Position: Q3 2022 in Review

Baystate Wealth Management sold out of GSK (GSK) in Q3 2022, closing a stake of 40 shares — an estimated $2K sold.

Baystate Wealth Management first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $239K in Q2 2016. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Baystate Wealth Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Baystate Wealth Management sold 40 GSK shares in Q3 2022, an estimated $2K.
  • Baystate Wealth Management first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • Baystate Wealth Management's GSK position peaked at $239K in Q2 2016.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Baystate Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.